Systematic Review
Copyright ©The Author(s) 2017.
World J Gastroenterol. Jul 21, 2017; 23(27): 4986-5003
Published online Jul 21, 2017. doi: 10.3748/wjg.v23.i27.4986
Table 4 Treatment of clostridium difficile infection in inflammatory bowel disease[3,4]
SeverityCriteriaTreatmentComments
First episode
Stop all non-CDI related antibiotic therapy if possible
Mild to moderate diseaseDiarrhea and symptoms not meeting criteria for severe diseaseMetronidazole 500 mg by mouth 3 times per day for 10 d to 14 dIn hospitalized patients with UC and nonsevere CDI, treatment with a vancomycin-containing regimen vs metronidazole alone resulted in fewer readmissions and shorter LOS[70]
or
Vancomycin 125 mg by mouth 4 times per day for 10 to 14 d
Severe diseaseSerum albumin < 3 g/dL AND one of the following:Vancomycin 125 mg by mouth 4 times per day for 10 to 14 d
WBC ≥ 15000 cells/mm3
Abdominal tenderness
Creatinine ≥ 133 μmol/L
Severe, complicated diseaseAdmission to intensive care unitVancomycin 500 mg by mouth or nasogastric tube 4 times per dayConsider early surgical consultation
Hypotension ± vasopressor requirementand
Fever ≥ 38.5 °CMetronidazole 500 mg IV every 8 h
Ileusand, if ileus,
Mental status changesVancomycin 500 mg in 500 mL saline as enema 4 times per day
WBC ≥ 35000 cells/mm3 or ≤ 2000 cells/mm3
Serum lactate ≥ 2.2 mmol/L
End organ failure
Recurrent CDI
First recurrenceMetronidazole 500 mg by mouth 3 times per day for 10 to 14 d
or
Vancomycin 125 mg by mouth 4 times per day for 10 to 14 d
or
Fidaxomicin 200 mg by mouth 2 times per day for 10 d
Second recurrence-Tapered and pulsed vancomycin
or
Fidaxomicin 200 mg by mouth 2 times per day for 10 d
Subsequent recurrence-Fecal microbiota transplant